Assignee
DEWPOINT THERAPEUTICS INC
US·4 granted patents·6 pending applications·11 citations·filing 2020–2024
Top patents by PatentIndex Score
10 records- 0192US11340231B2Methods of screening for condensate-associated specificity and uses thereofDEWPOINT THERAPEUTICS INC·Filed 2021·Granted May 24, 2022·6 cites·26 claims
- 0291US11493519B2Methods of characterizing condensate-associated characteristics of compounds and uses thereofDEWPOINT THERAPEUTICS INC·Filed 2020·Granted Nov 8, 2022·4 cites·36 claims
- 0386US12174198B2Methods of characterizing condensate-associated characteristics of compounds and uses thereofDEWPOINT THERAPEUTICS INC·Filed 2022·Granted Dec 24, 2024·1 cites·17 claims
- 0478US2025298031A1Methods of characterizing condensate-associated characteristics of compounds and uses thereofDEWPOINT THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0567US12422437B2Methods of screening for condensate-associated specificity and uses thereofDEWPOINT THERAPEUTICS INC·Filed 2022·Granted Sep 23, 2025·0 cites·27 claims
- 0657US2024145034A1Methods of identifying a condensate phenotype and uses thereofDEWPOINT THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0752US2026043792A1Methods of identifying selective condensate modulatorsDEWPOINT THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0848US2023314443A1Methods of identifying interactions of a compound and a condensate, or a component thereof, and uses thereofDEWPOINT THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0948US2024375024A1Methods of isolating a composition comprising a target moleculeDEWPOINT THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1045US2022365070A1Compositions, systems, and methods for identifying a compound that modulates one or more characteristics associated with a rbm20 condensate and/or a rbm20 polypeptideDEWPOINT THERAPEUTICS INC·Filed 2020·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →